Cryo-Cell International, Inc. (CCEL)

4.46 +0.81 (+22.19%) USD  |  NYAM  |  Oct 16, 11:21
More

Cryo-Cell International Research and Development Expense (Quarterly) : 0.0536M for Aug. 31, 2026

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
August 31, 2026 0.0536M
May 31, 2026 0.0998M
February 28, 2026 0.0658M
November 30, 2025 0.0848M
August 31, 2025 0.0616M
May 31, 2025 0.1317M
February 28, 2025 0.0981M
November 30, 2024 0.3046M
August 31, 2024 0.1939M
May 31, 2024 0.2411M
February 29, 2024 0.5029M
November 30, 2023 0.4438M
August 31, 2023 0.3441M
May 31, 2023 0.3047M
February 28, 2023 0.0788M
November 30, 2022 0.0764M
August 31, 2022 0.0803M
May 31, 2022 0.0809M
February 28, 2022 0.1472M
November 30, 2021 0.0304M
August 31, 2021 0.01M
May 31, 2021 0.0032M
February 28, 2021 0.0062M
November 30, 2020 0.0071M
August 31, 2020 0.0012M
Date Value
May 31, 2020 0.0098M
February 29, 2020 0.0057M
November 30, 2019 0.0169M
August 31, 2019 0.0024M
May 31, 2019 0.005M
February 28, 2019 0.0059M
November 30, 2018 0.0269M
August 31, 2018 0.0222M
May 31, 2018 0.0293M
February 28, 2018 0.0134M
November 30, 2017 0.0175M
August 31, 2017 0.0002M
May 31, 2017 0.0088M
February 28, 2017 0.0146M
November 30, 2016 0.0186M
August 31, 2016 0.0138M
May 31, 2016 0.012M
February 29, 2016 0.0087M
November 30, 2015 0.0133M
August 31, 2015 0.01M
May 31, 2015 0.0105M
February 28, 2015 0.012M
November 30, 2014 0.0138M
August 31, 2014 0.0179M
May 31, 2014 0.0183M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Dogecoin Cash, Inc. --
Privia Health Group, Inc. --
Strata Critical Medical, Inc. 1.006M
DocGo, Inc. 3.446M
Syra Health Corp. 0.0474M